Company profile

Perspectum

Perspectum has 1 AI-enabled medical device on the FDA list. The first decision was on September 6, 2022 and the most recent on September 6, 2022 (LiverMultiScan v5 (LMSv5)). Its most common review panel is Radiology (1 device).

1AI devices
2022First decision
2022Latest decision
1Specialties

Timeline

  1. LiverMultiScan v5 (LMSv5) · Radiology · LNH